check_circleStudy Completed

Dermatitis, Atopic

Bayer Identifier:

Trial_90044

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Efficacy and tolerance of methylprednisolone aceponate cream in different topic application regimes in patients with various kinds of eczema or atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

14 - N/A
  • -

  • -

Trial summary

Enrollment Goal
488
Trial Dates
February 1991 - July 1992
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Controlled, multicenter trial to establish the efficacy and tolerance of methylprednisolone aceponate (MPA) cream applied 1 x daily in comparison to MPA 1 x daily in combination with 1 x daily application of the vehicle and in comparison to MPA 2 x daily in patients with various kinds of eczema or atopic dermatitis.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.